Clinical Trials · NCT00924469
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Janssen Research & Development, LLC
- Enrollment
- 58
- Start date
- Nov 2009
- Locations
- 4 sites, United States
- Primary endpoint
- Testosterone Concentration in Prostate Tissue